ARCHITECT
Model 1P36-50 · Abbott GmbH · DI 00380740081935
DKB — Calibrators, Drug Mixture · Class II · 21 CFR 862.3200
KLT — Enzyme Immunoassay, Carbamazepine · Class II · 21 CFR 862.3645
UDILibrary device dossier · generated 2026-09-14 · sources: FDA GUDID, openFDA (recalls, MAUDE, 510(k)/PMA), FDA Data Dashboard (inspections, compliance actions), 510(k) summary documents.
Recall history (0)
No recalls linked in the loaded window.
Adverse-event reports — MAUDE (0)
Caveat (required reading): MAUDE report counts cannot be used to compute incidence rates or compare device safety. Reporting is incomplete, duplicated, and spikes with publicity; there is no denominator of devices in use. The peer line is a reporting baseline (average device in the same product code), not a risk measure.
| Month | This device (reports) | Product-code average (reports per device) |
|---|---|---|
| 2019-01 | 0 | 2 |
| 2019-08 | 0 | 1 |
| 2019-09 | 0 | 1 |
| 2019-10 | 0 | 1 |
| 2019-12 | 0 | 1 |
| 2020-04 | 0 | 1 |
| 2021-02 | 0 | 2 |
| 2022-04 | 0 | 1 |
| 2022-06 | 0 | 6 |
| 2023-11 | 0 | 6 |
| 2024-03 | 0 | 2 |
| 2025-02 | 0 | 2 |
| 2025-05 | 0 | 1.33 |
| 2025-12 | 0 | 3 |
Regulatory clearances
- K103627 SESE 2011-10-14 (k number procode)
Predicate lineage
K103627 — cites (transitively): K935374 (d1)
Lineage extracted from public 510(k) summary text (heuristic).
Manufacturer compliance record — Abbott GmbH
- VAI 2024-06-28 Abbott · 3 citations
- NAI 2020-01-10 Abbott · 0 citations
- NAI 2018-06-22 Abbott · 0 citations
- NAI 2018-02-01 Abbott · 0 citations
- NAI 2016-09-16 Abbott · 0 citations
- NAI 2013-06-13 Abbott GmbH · 0 citations
- NAI 2013-06-11 Abbott · 0 citations
- VAI 2013-03-08 Abbott · 0 citations
- NAI 2012-02-09 Abbott GmbH · 0 citations
- NAI 2011-10-05 Abbott · 0 citations
- VAI 2010-09-23 Abbott GmbH · 0 citations